Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Sundry Debtors

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,247 Cr₹1,189 Cr₹856 Cr₹621 Cr₹413 Cr

What is the latest Sundry Debtors ratio of NATCO PHARMA ?

The latest Sundry Debtors ratio of NATCO PHARMA is ₹1,247 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,247 Cr
Mar2024₹1,189 Cr
Mar2023₹856 Cr
Mar2022₹621 Cr
Mar2021₹413 Cr

How is Sundry Debtors of NATCO PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,247 Cr
4.85
Mar2024 ₹1,189 Cr
38.87
Mar2023 ₹856 Cr
37.95
Mar2022 ₹621 Cr
50.30
Mar2021 ₹413 Cr -

Compare Sundry Debtors of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,137.5 Cr -1.3% -7% -46.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 0.7% 0.4% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -1.7% 2% 16.7% Stock Analytics
CIPLA ₹126,308.0 Cr -0.9% 5.3% -3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr -0.1% 0.6% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 4.1% 7.6% -3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-7%

-46.1%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses